Friday, July 10, 2026

pharma · Eczema · GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency

Hong Kong Baptist

Hong Kong Baptist clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
18
Drugs
14
Patents
0
Intelligence · Clinical Programs

Hong Kong Baptist projects

5 ClinicalTrials.gov programs sponsored by Hong Kong Baptist.

Hong Kong Baptist has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. A Master Ganoderma Detox Tea

    Hong Kong Baptist University

    Eczema

    phase 2 other active

    1 trial
  2. Ceftriaxone 1000mg + doxycycline 100 mg

    Hong Kong Baptist University

    Neisseria Gonorrhoeae Infection

    phase 2 small molecule completed

    1 trial
  3. MaZiRenWan (MZRW)

    Hong Kong Baptist University

    Functional Gastrointestinal Disorders

    phase 2 small molecule completed

    1 trial
  4. ZL-1102 1% w/w gel BID for 16 weeks

    Hong Kong Baptist University

    Plaque Psoriasis

    phase 2 small molecule active

    1 trial
  5. mutual support group

    Hong Kong Baptist University

    Schizophrenia

    phase 2 other completed

    1 trial

Frequently asked questions

How many clinical projects does Hong Kong Baptist have?

5 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.